How do melatonin rhythms differ between blind and sighted people with non-24-hour sleep-wake disorder, and what do treatments reveal?

Why blindness makes the melatonin clock drift

Melatonin is a hormone released by the brain on a roughly 24-hour cycle, and its evening rise is one of the clearest readouts of where a person's internal clock stands. Ordinary daylight resets that clock each day, keeping it aligned with the outside world. When the eyes cannot send light information to the clock, the clock runs on its own slightly-longer-than-24-hour rhythm, so sleep and melatonin drift later and later. That is the setting in which non-24-hour sleep-wake disorder is most familiar, and reviews of drug treatment describe the condition as affecting both blind and sighted people while treating the blind group as the main population [4].

The same reviews note that melatonin treatment can shift the timing of the melatonin rhythm itself, not just sleep — in one sighted patient with the disorder, the circadian melatonin rhythm advanced with treatment [4]. That matters because it means the hormone profile can serve as both a diagnostic marker and a way to check whether a treatment is actually moving the clock.

In sighted people, the rhythm can look normal but arrive late

Sighted cases are uncommon and easy to confuse with ordinary delayed sleep or irregular habits, which is why objective confirmation is rarely reported [1]. In a detailed case of a 40-year-old sighted man with more than a decade of gradually worsening sleep timing, two 24-hour saliva melatonin profiles a week apart showed a melatonin rise and nighttime peak that were biologically consistent — the hormone was being made in the normal pattern — but the whole profile had shifted several hours later by the second test. That shift matched the roughly one-hour-per-day delay recorded in his sleep diary [1].

Two details from that case are worth holding onto. First, the man's sleep itself was not short or fragmented: he slept 9–10 hours with stable quality, and his daytime sleepiness score stayed low despite a referral for excessive sleepiness — the problem was timing, not sleep quantity [1]. Second, mild obstructive sleep apnea was found but did not explain the drifting circadian pattern [1]. So a free-running melatonin rhythm in a sighted person can exist alongside otherwise unremarkable sleep.

What treatment attempts reveal about the underlying clock

If the drift comes from a clock that is not being reset, then treatments that supply a strong timing signal should be able to stop it — and sometimes they do. In one sighted young man whose sleep diary and actigraphy showed about a two-hour daily delay, a course of total sleep deprivation followed by morning bright light and melatonin at night halted the free-running pattern immediately, and six months of the combination produced stable entrainment to a 24-hour cycle with maintained compliance [3]. In the 40-year-old case, a melatonin receptor agonist taken an hour before a fixed 9 p.m. bedtime, combined with morning bright light and behavioral schedule anchoring, was the chosen strategy [1].

Success is not the norm everywhere, though. Among six sighted children and adolescents with the disorder — five of whom had autism spectrum disorder, three ADHD, and two anxiety disorders — free-running cycles ranged from 24 to 29 hours, and entrainment strategies using melatonin, bright light, and behavioral interventions had variable success. Long-term entrainment was rarely achieved because of side effects, inconsistent adherence, and the burden on families, and several families chose to keep a flexible, free-running schedule and reported better mood and function that way [2].

Read together, these treatment results suggest the clock in sighted patients is not necessarily broken — it can respond to a well-timed melatonin signal and light exposure — but that keeping it reset demands consistency that is hard to sustain, particularly in children with additional developmental conditions [2][3]. The variable outcomes also mean treatment response cannot by itself tell us whether a given sighted patient's rhythm is driven by the same mechanism as in blind patients.

What the comparison still cannot settle

The direct blind-versus-sighted comparison the question asks for is thinner than it first appears. The sighted case reports describe melatonin profiles in detail but do not measure blind patients alongside them [1][3], and the pediatric series included only sighted children [2]. The pharmacological review covers both populations and reports that melatonin rhythm timing can shift with treatment in a sighted patient, but it does not lay out a side-by-side rhythm comparison [4]. A general review of melatonin and sleep links delayed melatonin rhythms to the disorder and discusses melatonin as a drug for blind people with the condition, again without a clean head-to-head comparison [5].

So the honest summary is this: the blind form is well explained by loss of light input to the clock, while sighted cases show melatonin rhythms that can be normal in shape yet progressively late, and treatments that sometimes re-anchor the rhythm and sometimes fail. Whether sighted and blind patients differ in the underlying rhythm biology, rather than mainly in how the disorder arises and how well treatment sticks, is a question these studies raise but do not answer.

Sources used in this answer

Related research questions